Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H25FN4O2 |
Molecular Weight | 348.4151 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H](NC(=O)C1=NN(CCCCCF)C2=CC=CC=C12)C(N)=O
InChI
InChIKey=WCBYXIBEPFZUBG-HNNXBMFYSA-N
InChI=1S/C18H25FN4O2/c1-12(2)15(17(20)24)21-18(25)16-13-8-4-5-9-14(13)23(22-16)11-7-3-6-10-19/h4-5,8-9,12,15H,3,6-7,10-11H2,1-2H3,(H2,20,24)(H,21,25)/t15-/m0/s1
Molecular Formula | C18H25FN4O2 |
Molecular Weight | 348.4151 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:16:45 UTC 2023
by
admin
on
Sat Dec 16 10:16:45 UTC 2023
|
Record UNII |
3L83B2298V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7025
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-5F-AB-PINACA
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5F-AB-PINACA
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
PRIMARY | |||
|
3L83B2298V
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
PRIMARY | |||
|
DTXSID40100997
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
PRIMARY | |||
|
1800101-60-3
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
PRIMARY | |||
|
91936927
Created by
admin on Sat Dec 16 10:16:45 UTC 2023 , Edited by admin on Sat Dec 16 10:16:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
EC50
|
||
|
TARGET -> AGONIST |
EC50
|
||
|
RACEMATE -> ENANTIOMER | |||
|
TARGET -> AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |